Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2025 investor ...

Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership ...

Roundtable (RT) selections published on 7/11/2025 listed 26 dividend picks for 2025. Click for more on Dividend Quick Picks & ...

This was the stock's second consecutive day of losses.

Becton, Dickinson (NYSE:BDX) declares $1.04/share quarterly dividend, in line with previous. Forward yield 2.29% Payable Sept. 30; for shareholders of record Sept. 8; ex-div Sept. 8. See BDX Dividend ...

Becton Dickinson (BDX) announced the first pharma-sponsored combination product clinical trial using the BD Libertas Wearable Injector for ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Becton Dickinson & Co. closed 29.02% below its 52-week high of $251.99, which the company reached on February 3rd.

The selection of BD LibertasTM Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pre-clini ...

Universal Health Realty's dividend has been hiked annually for four decades. That's a pretty good streak, even though it ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

The medical devices market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by technological advancements, a ...